|  |  | TABLE OF CONTENTS
|  |  |  | | Volume 37, Issue 2 (January 2018) |  | In this issue Reviews Original Articles Short Communications Also new    AOP | |  |  | |  | Reviews | Top |  | The HIF and other quandaries in VHL disease D Tarade and M Ohh Oncogene 2018 37: 139-147; advance online publication, September 18, 2017; 10.1038/onc.2017.338 Abstract | Full Text |  |  |  | Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer OPEN L Liu, C C Wong, B Gong and J Yu Oncogene 2018 37: 148-159; advance online publication, September 18, 2017; 10.1038/onc.2017.313 Abstract | Full Text |  | Original Articles | Top |  | Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors OPEN J S K Chan, M K Sng, Z Q Teo, H C Chong, J S Twang and N S Tan Oncogene 2018 37: 160-173; advance online publication, September 11, 2017; 10.1038/onc.2017.319 Abstract | Full Text |  |  |  | Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking OPEN D P Corkery, L E Clarke, S Gebremeskel, J Salsman, J Pinder, C Le Page, L Meunier, Z Xu, A-M Mes-Masson, J N Berman, B Johnston and G Dellaire Oncogene 2018 37: 174-184; advance online publication, September 11, 2017; 10.1038/onc.2017.318 Abstract | Full Text |  |  |  | A system for detecting high impact-low frequency mutations in primary tumors and metastases M Anjanappa, Y Hao, E R Simpson, P Bhat-Nakshatri, J B Nelson, S A Tersey, R G Mirmira, A A Cohen-Gadol, M R Saadatzadeh, L Li, F Fang, K P Nephew, K D Miller, Y Liu and H Nakshatri Oncogene 2018 37: 185-196; advance online publication, September 11, 2017; 10.1038/onc.2017.322 Abstract | Full Text |  |  |  | Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer A R Rowson-Hodel, J H Wald, J Hatakeyama, W K O'Neal, J R Stonebraker, K VanderVorst, M J Saldana, A D Borowsky, C Sweeney and K L Carraway, 3rd Oncogene 2018 37: 197-207; advance online publication, September 11, 2017; 10.1038/onc.2017.327 Abstract | Full Text |  |  |  | EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer H Yamaguchi, Y Du, K Nakai, M Ding, S-S Chang, J L Hsu, J Yao, Y Wei, L Nie, S Jiao, W-C Chang, C-H Chen, Y Yu, G N Hortobagyi and M-C Hung Oncogene 2018 37: 208-217; advance online publication, September 18, 2017; 10.1038/onc.2017.311 Abstract | Full Text |  |  |  | Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes A Mizrahi, A Barzilai, D Gur-Wahnon, I Z Ben-Dov, S Glassberg, T Meningher, E Elharar, M Masalha, J Jacob-Hirsch, H Tabibian-Keissar, I Barshack, J Roszik, R Leibowitz-Amit, Y Sidi and D Avni Oncogene 2018 37: 218-230; advance online publication, September 18, 2017; 10.1038/onc.2017.315 Abstract | Full Text |  |  |  | Small molecules targeted to the microtubule–Hec1 interaction inhibit cancer cell growth through microtubule stabilization OPEN M Ferrara, G Sessa, M Fiore, F Bernard, I A Asteriti, E Cundari, G Colotti, S Ferla, M Desideri, S Buglioni, D Trisciuoglio, D Del Bufalo, A Brancale and F Degrassi Oncogene 2018 37: 231-240; advance online publication, September 18, 2017; 10.1038/onc.2017.320 Abstract | Full Text |  |  |  | DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression D N Debruyne, L Turchi, F Burel-Vandenbos, M Fareh, F Almairac, V Virolle, D Figarella-Branger, N Baeza-Kallee, P Lagadec, V kubiniek, P Paquis, D Fontaine, M-P Junier, H Chneiweiss and T Virolle Oncogene 2018 37: 241-254; advance online publication, September 18, 2017; 10.1038/onc.2017.323 Abstract | Full Text |  |  |  | MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells J-Y Yoo, W S Yang, J H Lee, B G Kim, R R Broaddus, J M Lim, T H Kim and J-W Jeong Oncogene 2018 37: 255-262; advance online publication, September 18, 2017; 10.1038/onc.2017.335 Abstract | Full Text |  | Short Communications | Top |  | Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer T Ando, D Charindra, M Shrestha, H Umehara, I Ogawa, M Miyauchi and T Takata Oncogene 2018 37: 263-270; advance online publication, September 18, 2017; 10.1038/onc.2017.321 Abstract | Full Text |  |  |  | Atypical E2Fs inhibit tumor angiogenesis OPEN B G M W Weijts, B Westendorp, B T Hien, L M Martínez-López, M Zijp, I Thurlings, R E Thomas, S Schulte-Merker, W J Bakker and A de Bruin Oncogene 2018 37: 271-276; advance online publication, September 18, 2017; 10.1038/onc.2017.336 Abstract | Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | | | |
No comments:
Post a Comment